Pyridoxamine improves metabolic and microcirculatory complications associated with non ‐alcoholic fatty liver disease

ConclusionPM modulates oxidative stress, AGEs, TNF ‐α transcripts levels and metabolic disturbances, being a potential treatment for NAFLD‐associated microcirculatory and metabolic complications.

Source: Microcirculation - December 24, 2019 Category: Research Authors: Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Edgar Eduardo Ilaquita Flores, Karine Lino Rodrigues, Anissa Daliry Tags: ORIGINAL RESEARCH Source Type: research